3579 results for «318»
3579 results
AICT-AsiaPCR 2023 Closing Ceremony
22 Sep 2023 – From AICT-AsiaPCR 2023
As AICT-AsiaPCR 2023 draws to a close, it's time to say thank you to the 950 participants and all those who helped make the conference a success, both on stage and behind the scenes.
Revolutionising coronary calcium treatment: unleashing the potential of intravascular lithotripsy
21 Sep 2023 – From AICT-AsiaPCR 2023
Over the last five years, we have learned that there is a new tool for treating calcium, the greatest enemy of interventional cardiology, which can take various forms: intravascular lithotripsy. In this session, look at how to master this technique in different scenarios, from eccentric calcified...
Clinical cases - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
A hybrid approach in complex PCI: can DES and DCB be complementary?
21 Sep 2023 – From AICT-AsiaPCR 2023
Watch this case-based session to follow discussion about how to choose between DES & DCB, how both can be complementary in diffuse disease as well as in complex PCI, and how physiology and imaging can help guiding PCI, and follow a patient's treatment live.
Abstracts - Coronary interventions - Session 2
06 Oct 2022 – From AICT-AsiaPCR 2022
Leave nothing behind: DCB-only PCI strategy - How DCB evidence has changed today's practice?
22 Sep 2023 – From AICT-AsiaPCR 2023
This session offers an opportunity to stay informed about the recent developments in the International DCB Consensus Group, gain insights into the latest clinical data and real-world experiences related to drug-coated balloon (DCB)-only PCI, understand the safety aspects of DCB in managing complex PCI cases, and...
The importance of SEE-PREP-TREAT in left main bifurcation
22 Sep 2023 – From AICT-AsiaPCR 2023
This session is recommended for you if you are seeking insights into the advantages of using IVUS imaging over visual assessment for better outcomes in left main bifurcation procedures. Discuss with experts the benefits of using RotaCUT in lesion preparation for left main bifurcation and explore...
Clinical cases - Coronary interventions - Session 5
07 Oct 2022 – From AICT-AsiaPCR 2022
Abstracts - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Essentials of lifetime management in patient undergoing TAVI using novel balloon expandable Myval Octacor THV
22 Sep 2023 – From AICT-AsiaPCR 2023
This session with a LIVE case provides information about the Octacor transcatheter heart valve technology, highlighting its procedural and clinical benefits. It also covers the Octalign technique, which ensures precise alignment of commissural and coronary access, and discusses the precise sizing, positioning, and deployment of Octacor THV.
Abstracts - Coronary interventions - Session 3
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 4
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 6
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 7
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Structural interventions - Session 9
07 Oct 2022 – From AICT-AsiaPCR 2022
Clinical cases - Coronary interventions - Session 8
07 Oct 2022 – From AICT-AsiaPCR 2022
The impact of COVID-19 pandemic on interventional cardiologists in training
23 Oct 2020
In collaboration with EuroIntervention Journal
The authors decided to create a survey tailored for ICTs in order to assess the changes in their training. Capturing the essence of the responses may help to identify the most appropriate strategies to provide the highest standards and skills achievements in COVID-19...
TRISCEND II trial: Randomized comparison of transcatheter valve replacement vs. optimal medical therapy for severe tricuspid regurgitation
04 Nov 2024
Alex Sticchi provides his take on the results of the TRISCEND II trial presented by Susheel K. Kodali and Suzanne V. Arnold at TCT 2024 in Washington.
Also watch the interview with Susheel K. Kodali
Author
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
